167 related articles for article (PubMed ID: 26393852)
21. [Extended release oxycodone. An oral opioid analgesic for cancer patients with chronic pain].
Taeron C
Rev Infirm; 2002 Nov; (85):47-9. PubMed ID: 12510533
[No Abstract] [Full Text] [Related]
22. Model-based Meta-analysis to Compare Primary Efficacy-endpoint, Efficacy-time Course, Safety, and Tolerability of Opioids Used in the Management of Osteoarthritic Pain in Humans.
Alhaj-Suliman SO; Milavetz G; Salem AK
Curr Drug Metab; 2020; 21(5):390-399. PubMed ID: 32407270
[TBL] [Abstract][Full Text] [Related]
23. Comparison of controlled-release and immediate-release oxycodone tablets in patients with cancer pain.
Kaplan R; Parris WC; Citron ML; Zhukovsky D; Reder RF; Buckley BJ; Kaiko RF
J Clin Oncol; 1998 Oct; 16(10):3230-7. PubMed ID: 9779696
[TBL] [Abstract][Full Text] [Related]
24. Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).
Pergolizzi J; Böger RH; Budd K; Dahan A; Erdine S; Hans G; Kress HG; Langford R; Likar R; Raffa RB; Sacerdote P
Pain Pract; 2008; 8(4):287-313. PubMed ID: 18503626
[TBL] [Abstract][Full Text] [Related]
25. A comparative study of oxycodone and morphine in a multi-modal, tissue-differentiated experimental pain model.
Staahl C; Christrup LL; Andersen SD; Arendt-Nielsen L; Drewes AM
Pain; 2006 Jul; 123(1-2):28-36. PubMed ID: 16600508
[TBL] [Abstract][Full Text] [Related]
26. Oral oxycodone: new preparation. No better than oral morphine.
Prescrire Int; 2003 Jun; 12(65):83-4. PubMed ID: 12825566
[TBL] [Abstract][Full Text] [Related]
27. Long-term efficacy and safety of oxycodone-naloxone prolonged-release formulation (up to 180/90 mg daily) - results of the open-label extension phase of a phase III multicenter, multiple-dose, randomized, controlled study.
Dupoiron D; Stachowiak A; Loewenstein O; Ellery A; Kremers W; Bosse B; Hopp M
Eur J Pain; 2017 Oct; 21(9):1485-1494. PubMed ID: 28474460
[TBL] [Abstract][Full Text] [Related]
28. Modeling the economic and health consequences of managing chronic osteoarthritis pain with opioids in Germany: comparison of extended-release oxycodone and OROS hydromorphone.
Ward A; Bozkaya D; Fleischmann J; Dubois D; Sabatowski R; Caro JJ
Curr Med Res Opin; 2007 Oct; 23(10):2333-45. PubMed ID: 17697453
[TBL] [Abstract][Full Text] [Related]
29. Oxycodone.
Kalso E
J Pain Symptom Manage; 2005 May; 29(5 Suppl):S47-56. PubMed ID: 15907646
[TBL] [Abstract][Full Text] [Related]
30. Use of oxycodone controlled-release immediately after NSAIDs: a new approach to obtain good pain control.
Tessaro L; Bandieri E; Costa G; Fornasier G; Iorno V; Pizza C; Pastacaldi G; Micheletto G
Eur Rev Med Pharmacol Sci; 2010 Feb; 14(2):113-21. PubMed ID: 20329570
[TBL] [Abstract][Full Text] [Related]
31. [Pain relief therapy: Oxycodone--a new retard opioid with effective analgesic action].
Orthopade; 1998 Jul; 27(7 Suppl):1-3. PubMed ID: 9725146
[No Abstract] [Full Text] [Related]
32. Dose-ranging study of oxycodone for chronic pain in advanced cancer.
Glare PA; Walsh TD
J Clin Oncol; 1993 May; 11(5):973-8. PubMed ID: 8487060
[TBL] [Abstract][Full Text] [Related]
33. Oxycodone-induced analgesic effects in a bone cancer pain model in mice.
Kato A; Minami K; Ito H; Tomii T; Matsumoto M; Orita S; Kihara T; Narita M; Suzuki T
Oncology; 2008; 74 Suppl 1():55-60. PubMed ID: 18758199
[TBL] [Abstract][Full Text] [Related]
34. Opioid Concentrations in Oral Fluid and Plasma in Cancer Patients With Pain.
Heiskanen T; Langel K; Gunnar T; Lillsunde P; Kalso EA
J Pain Symptom Manage; 2015 Oct; 50(4):524-32. PubMed ID: 25242020
[TBL] [Abstract][Full Text] [Related]
35. The use of high doses of oxycodone in an acute palliative care unit.
Mercadante S; Ferrera P; David F; Casuccio A
Am J Hosp Palliat Care; 2011 Jun; 28(4):242-4. PubMed ID: 20826490
[TBL] [Abstract][Full Text] [Related]
36. Oxycodone for pain management in the latent phase of labour - A pragmatic trial.
Kinnunen M; Kokki H; Hautajärvi H; Tuovinen K; Kokki M
Acta Anaesthesiol Scand; 2020 May; 64(5):685-690. PubMed ID: 31950485
[TBL] [Abstract][Full Text] [Related]
37. Therapy switching in patients receiving long-acting opioids.
Berger A; Hoffman DL; Goodman S; Delea TE; Seifeldin R; Oster G
Ann Pharmacother; 2004 Mar; 38(3):389-95. PubMed ID: 14742831
[TBL] [Abstract][Full Text] [Related]
38. Observations on the urine metabolic ratio of oxymorphone to oxycodone in pain patients.
Yee DA; Best BM; Atayee RS; Pesce AJ
J Anal Toxicol; 2012 May; 36(4):232-8. PubMed ID: 22511697
[TBL] [Abstract][Full Text] [Related]
39. Efficacy of oxycodone/paracetamol for patients with bone-cancer pain: a multicenter, randomized, double-blinded, placebo-controlled trial.
Sima L; Fang WX; Wu XM; Li F
J Clin Pharm Ther; 2012 Feb; 37(1):27-31. PubMed ID: 21208247
[TBL] [Abstract][Full Text] [Related]
40. Minimising the misuse of oxycodone and other pharmaceutical opioids in Australia.
Hall WD; Farrell MP
Med J Aust; 2011 Sep; 195(5):248-9. PubMed ID: 21895579
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
